The New York Times Magazine published an article last week about the lesser-discussed ways selective serotonin reuptake inhibitors, such as fluoxetine and paroxetine, which are frequently prescribed to treat depression and anxiety, affect adolescents‘ sexual development.

Post-SSRI sexual dysfunction is a condition in which sexual side effects from SSRIs (and serotonin and norepinephrine reuptake inhibitors) persist after an individual stops taking the medication. Documented side effects include a loss of sexual desire and arousal, numbness in one’s sexual anatomy, and erectile dysfunction.

Recommended Stories

RFK Jr. moves to shake up vaccines in pregnancy by putting two OB-GYNs on advisory panel

University policy suggests disabled people can’t consent to sex

Ordinary unhappiness: Review of Khameer Kidia’s ‘Empire of Madness’